Department of Paediatrics, Monash University, Clayton, Australia.
Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children's Research Institute (MCRI), Parkville, Australia.
Hum Vaccin Immunother. 2021 Aug 3;17(8):2578-2585. doi: 10.1080/21645515.2021.1901544. Epub 2021 Apr 9.
Acute disseminated encephalomyelitis (ADEM) is an autoimmune, central nervous system demyelinating disorder that follows antecedent immunologic challenges, such as infection or vaccination. This study aimed to investigate the potential association between routine childhood vaccinations and ADEM. Children under 7 years of age admitted to the two tertiary level pediatric hospitals in Victoria, Australia with ADEM from 2000-2015 had their clinical information linked to vaccination records from the Australian Childhood Immunization Register. Chart review was undertaken utilizing the Brighton Collaboration ADEM criteria. The self-controlled case-series (SCCS) methodology was employed to determine the relative incidences of ADEM post-vaccination in two risk intervals: 5-28 days and 2-42 days. Forty-six cases were eligible for SCCS analysis with a median age of 3.2 years. Of the forty-six cases, three were vaccine proximate cases and received vaccinations 23, 25 and 28 days before ADEM onset. Two vaccine proximate cases received their 4-year-old scheduled vaccinations (MMR and DTPa-IPV) and one vaccine proximate case the 1-year old scheduled vaccinations (MMR and Hib-MenC). The relative incidence of ADEM during the narrow and broad risk intervals were 1.041 (95% CI 0.323-3.356, = 0.946) and 0.585 (95% CI 0.182-1.886, = 0.370) respectively. Sensitivity analyses did not yield any substantial deviations. These results do not provide evidence of an association between vaccinations routinely provided to children aged under 7 years in Australia and the incidence of ADEM. However, these results should be interpreted with caution as the number of ADEM cases identified was limited and further research is warranted.
急性播散性脑脊髓炎(ADEM)是一种自身免疫性中枢神经系统脱髓鞘疾病,继发于感染或疫苗接种等免疫性挑战。本研究旨在探讨常规儿童疫苗接种与 ADEM 之间的潜在关联。2000-2015 年期间,澳大利亚维多利亚州两家三级儿科医院收治了年龄在 7 岁以下的 ADEM 患儿,他们的临床信息与澳大利亚儿童免疫登记处的疫苗接种记录相关联。采用布莱顿协作 ADEM 标准进行图表审查。采用自我对照病例系列(SCCS)方法,确定疫苗接种后 5-28 天和 2-42 天两个风险间隔内 ADEM 的相对发病率。46 例符合 SCCS 分析标准,中位年龄为 3.2 岁。在这 46 例病例中,有 3 例为疫苗接近病例,在 ADEM 发病前 23、25 和 28 天接种了疫苗。2 例疫苗接近病例接种了 4 岁常规疫苗(MMR 和 DTPa-IPV),1 例疫苗接近病例接种了 1 岁常规疫苗(MMR 和 Hib-MenC)。在狭义和广义风险间隔内,ADEM 的相对发病率分别为 1.041(95%CI 0.323-3.356, = 0.946)和 0.585(95%CI 0.182-1.886, = 0.370)。敏感性分析未产生任何实质性偏差。这些结果并未提供证据表明澳大利亚常规为 7 岁以下儿童接种疫苗与 ADEM 的发病率之间存在关联。然而,由于确定的 ADEM 病例数量有限,因此应谨慎解释这些结果,需要进一步研究。